Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,480 | 11,700 | 17,460 | 24,470 | 4,160 |
| TOTAL | $3,480 | $11,700 | $17,460 | $24,470 | $4,160 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 12,020 | 14,980 | 17,490 | 643,690 | 151,630 |
| TOTAL | $12,020 | $14,980 | $17,490 | $643,690 | $151,630 |
| Total Assets | $15,500 | $26,680 | $34,950 | $668,160 | $155,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 3,270 | 10,850 | 10 |
| Accounts payable and accrued liabilities | 26,040 | 23,920 | 42,820 | 123,990 | 13,210 |
| Accrued Expenses | 20,300 | 36,810 | 48,940 | 52,960 | 10,600 |
| Other current liabilities | 8,930 | 9,100 | 12,530 | 10,920 | 7,220 |
| TOTAL | $55,390 | $69,980 | $107,680 | $201,540 | $31,045 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 65,080 | 65,080 | 175,940 | 503,440 | 480 |
| TOTAL | $65,080 | $65,150 | $176,170 | $522,350 | $11,476 |
| Total Liabilities | $120,470 | $135,130 | $283,850 | $723,890 | $42,521 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 60 | 20 |
| Other shareholders' equity | -2,160 | -2,860 | 30 | -6,130 | -1,840 |
| TOTAL | $1,078,940 | $1,074,350 | $1,073,300 | $1,031,820 | $407,030 |
| Total Liabilities And Equity | $1,199,410 | $1,209,480 | $1,357,150 | $1,755,710 | $449,551 |